Last update: Aug. 21, 2016

Erythromycin (topical use)

Very Low Risk for breastfeeding


Safe. Compatible.
Minimal risk for breastfeeding and infant.

La pequeña dosis y la escasa absorción plasmática de la mayoría de preparaciones dermatológicas u oftalmológicas tópicas hacen poco probable el paso de cantidad significativa a leche materna.

No aplicar sobre el pecho para evitar que el lactante lo ingiera; caso necesario, aplicar tras una toma y limpiar bien con agua antes de la próxima.

Conviene evitar la aplicación sobre el pezón de cremas, geles y otros producto de aplicación local que contengan parafina (aceite mineral) para que el lactante no lo absorba.

Academia Americana de Pediatría: medicación usualmente compatible con la lactancia.

Listado de medicamentos esenciales OMS 2002: compatible con la lactancia.

Alternatives

We do not have alternatives for Erythromycin (topical use) since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Other names

Erythromycin (topical use) in other languages or writings:

Group

Erythromycin (topical use) belongs to this group or family:

Tradenames

Main tradenames from several countries containing Erythromycin (topical use) in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 0 (cutánea) %
Molecular weight 734 daltons
Protein Binding 70 - 95 %
Tmax 1 - 4 hours
T1/2 1,5 - 2,5 hours
M/P ratio 0,9 - 1,6 -
Theoretical Dose 0 mg/Kg/d
Relative Dose 0 %

References

  1. Butler DC, Heller MM, Murase JE. Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation. J Am Acad Dermatol. 2014 Mar;70(3):417.e1-10; quiz 427. Abstract
  2. Kong YL, Tey HL. Treatment of acne vulgaris during pregnancy and lactation. Drugs. 2013 Jun;73(8):779-87. Abstract
  3. Fluhr JW, Degitz K. [Antibiotics, azelaic acid and benzoyl peroxide in topical acne therapy]. J Dtsch Dermatol Ges. 2010 Abstract
  4. Concin N, Hofstetter G, Plattner B, Tomovski C, Fiselier K, Gerritzen K, Fessler S, Windbichler G, Zeimet A, Ulmer H, Siegl H, Rieger K, Concin H, Grob K. Mineral oil paraffins in human body fat and milk. Food Chem Toxicol. 2008 Abstract
  5. Worret WI, Fluhr JW. [Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid]. J Dtsch Dermatol Ges. 2006 Abstract
  6. Noti A, Grob K, Biedermann M, Deiss U, Brüschweiler BJ. Exposure of babies to C15-C45 mineral paraffins from human milk and breast salves. Regul Toxicol Pharmacol. 2003 Abstract

Total visits

11,244

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by La Liga de la Leche, España from Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM